Way to Go/No-Go!

Por Lesser, Glenn J
Publicado no Neuro Oncol (2020)

Creating clinical trial designs that incorporate clinical outcome assessments

Por Gilbert, Mark R., Rubinstein, Lawrence, Lesser, Glenn
Publicado no Neuro Oncol (2016)

BI-18 CELLULAR MICROPARTICLES AS BLOOD-BORNE ENDOTHELIAL BIOMARKERS IN PATIENTS WITH MALIGNANT GLIOMAS

Por Lesser, Glenn, Harmon, Michele, Khan, Islam, Whitlow, Christopher, Brown, William
Publicado no Neuro Oncol (2014)

CSIG-02. VAL-083 INHIBITS PROLIFERATION OF A PANEL OF EIGHT GLIOBLASTOMA STEM CELL LINES: DOWNREGULATION OF BDR4 AS A NOVEL ANTI-NEOPLASTIC MECHANISM

Por Fernandez, Elise, Steino, Anne, Lesser, Glenn, Bacha, Jeffrey, Brown, Dennis, Kwatra, Madan
Publicado no Neuro Oncol (2018)

Analysis of salivary fluid and chemosensory functions in patients treated for primary malignant brain tumors

Por Mirlohi, Susan, Duncan, Susan E., Harmon, Michele, Case, Doug, Lesser, Glenn, Dietrich, Andrea M.
Publicado em 2014

CSIG-26. HETEROGENEITY OF EGFRvIII-POSITIVE GLIOBLASTOMA STEM CELLS: IMPLICATIONS FOR PERSONALIZED DRUG DEVELOPMENT

Por Kwatra, Madan, Nanni, Cory, Roberts, Callie, Kwatra, Shawn, Lesser, Glenn J, Gilbert, Mark R
Publicado no Neuro Oncol (2017)

EXTH-46. A PRECISION MEDICINE APPROACH TO TARGET EGFRvIII IN GBM: OSIMERTINIB (AZD9291) INHIBITS THE GROWTH OF EGFRvIII-POSITIVE GLIOBLASTOMA STEM CELLS AND INCREASES SURVIVAL OF M...

Por Kwatra, Madan, Nanni, Cory, Roberts, Callie, Kwatra, Shawn, Gilbert, Mark R, Lesser, Glenn J
Publicado no Neuro Oncol (2017)

Immunosuppression in Patients with High Grade Gliomas Treated with Radiation and Temozolomide

Por Grossman, Stuart A., Ye, Xiaobu, Lesser, Glenn, Sloan, Andrew, Carraway, Hetty, Desideri, Serena, Piantadosi, Steven
Publicado em 2011

Phase II preradiation R115777 (tipifarnib) in newly diagnosed GBM with residual enhancing disease

Por Lustig, Robert, Mikkelsen, Tom, Lesser, Glenn, Grossman, Stuart, Ye, Xiaobu, Desideri, Serena, Fisher, Joy, Wright, John
Publicado em 2008

Prolonged Regression of Metastatic Leptomeningeal Breast Cancer That Has Failed Conventional Therapy: A Case Report and Review of the Literature

Por Vincent, Andrew, Lesser, Glenn, Brown, Doris, Vern-Gross, Tamara, Metheny-Barlow, Linda, Lawrence, Julia, Chan, Michael
Publicado em 2013

An Automated System for Detecting Nonadherence in Laboratory Testing and Monitoring for Myelosuppression in Patients Receiving Self-Administered Oral Chemotherapy

Por Morrell, Robert M., Tooze, Janet A., Harmon, Michele S., Carter, Annette F., DeTroye, Alisha T., Lesser, Glenn J.
Publicado em 2013

Anaplastic ganglioglioma: a report of three cases and review of the literature

Por Lucas, John Thomas, Huang, Andrew Jonathan, Mott, Ryan T., Lesser, Glenn J., Tatter, Stephen Bradley, Chan, Michael David
Publicado no J Neurooncol (2015)

Suramin and radiotherapy in newly diagnosed glioblastoma: Phase 2 NABTT CNS Consortium study

Por Laterra, John J., Grossman, Stuart A., Carson, Kathryn A., Lesser, Glenn J., Hochberg, Fred H., Gilbert, Mark R.
Publicado em 2004

SM-07 A PILOT STUDY OF HIGH-DOSE INFLUENZA VACCINE IMMUNOGENICITY IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM MALIGNANCY

Por Strowd, Roy, Russell, Gregory, Harmon, Michele, Carter, Annette, Chan, Michael, Tatter, Stephen, Laxton, Adrian, High, Kevin, Lesser, Glenn
Publicado no Neuro Oncol (2014)

Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma

Por Phuphanich, Surasak, Carson, Kathryn A., Grossman, Stuart A., Lesser, Glenn, Olson, Jeffrey, Mikkelsen, Tom, Desideri, Serena, Fisher, Joy D.
Publicado em 2008

Relapsing intracranial plasma cell granuloma: A case report

Por RENFROW, JACLYN J., MITCHELL, JERRY W., GOODMAN, MICHAEL, MELLEN, LEIGH A., WILSON, JOHN A., MOTT, RYAN T., LESSER, GLENN J.
Publicado em 2014

Enhancing Irreversible Electroporation by Manipulating Cellular Biophysics with a Molecular Adjuvant

Por Ivey, Jill W., Latouche, Eduardo L., Richards, Megan L., Lesser, Glenn J., Debinski, Waldemar, Davalos, Rafael V., Verbridge, Scott S.
Publicado no Biophys J (2017)

Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma

Por Grossman, Stuart A., Olson, Jeffrey, Batchelor, Tracy, Peereboom, David, Lesser, Glenn, Desideri, Serena, Ye, Xiaobu, Hammour, Tarek, Supko, Jeffrey G.
Publicado em 2008

Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration – a retrospective stu...

Por Lamar, Zanetta S., Dothard, Andrew, Kennedy, LeAnne, Isom, Scott, Robinson, Mac, Vaidya, Rakhee, Hurd, David, McClain, Donald, Lesser, Glenn
Publicado no Leuk Lymphoma (2017)

NCMP-11. THE CANCER AND COGNITION CLINIC AT WAKE FOREST BAPTIST HOSPITAL: SATISFYING AN UNMET NEED

Por Cummings, Tiffany, Giles, Abigail, Liberatore, Mary, Laxton, Adrian, Carter, Annette, Tatter, Stephen, Chan, Michael, Lesser, Glenn, Strowd, Roy, Cramer, Christina
Publicado no Neuro Oncol (2019)